Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence

European Journal of Cancer

Volumn 47, Issue 12, 2011, Pages 1837-1845

  Belt, E J Th ^a   Fijneman, R J A ^a   Van Den Berg, E G ^a   Bril, H ^b   Delis Van Diemen, P M ^a   Tijssen, M ^a   Van Essen, H F ^a   De Lange De Klerk, E S M ^a   Belien J A M ^a   Stockmann, H B A C ^b   Meijer, S ^a   Meijer, G A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Kennemer Gasthuis ^*  (Netherlands)

Author keywords

Biomarker; Colon cancer; Disease recurrence; Lamin A C; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; FORMALDEHYDE; LAMIN A; LAMIN C; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER TISSUE; COLON CANCER; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MICROSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LAMIN TYPE A; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; RECURRENCE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 80955181165     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.04.025     Document Type: Article

References (30)

1. J. Weitz, M. Koch, and J. Debus Colorectal cancer Lancet 365 9454 2005 153 165 (Pubitemid 40091806)
2. L.H. Sobin, and I.D. Fleming TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer 80 9 1997 1803 1804
3. S. Gill, C.L. Loprinzi, and D.J. Sargent Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22 10 2004 1797 1806 (Pubitemid 41095169)
4. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 1999;17(5):1356-1363.
5. E. Mamounas, S. Wieand, and N. Wolmark Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol 17 5 1999 1349 1355 (Pubitemid 29220839)
6. M. Hermsen, C. Postma, and J. Baak Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability Gastroenterology 123 4 2002 1109 1119
7. M.S. Pino, and D.C. Chung The chromosomal instability pathway in colon cancer Gastroenterology 138 6 2010 2059 2072
8. C.R. Boland, and A. Goel Microsatellite instability in colorectal cancer Gastroenterology 138 6 2010 2073 2087 [e2073]
9. K. Soreide, E.A. Janssen, H. Soiland, H. Korner, and J.P. Baak Microsatellite instability in colorectal cancer Br J Surg 93 4 2006 395 406
10. N.D. Willis, T.R. Cox, and S.F. Rahman-Casans Lamin A/C is a risk biomarker in colorectal cancer PLoS One 3 8 2008 e2988
11. J.L. Broers, C.J. Hutchison, and F.C. Ramaekers Laminopathies J Pathol 204 4 2004 478 488 (Pubitemid 39468159)
12. B.C. Capell, and F.S. Collins Human laminopathies: nuclei gone genetically awry Nat Rev Genet 7 12 2006 940 952 (Pubitemid 44871397)
13. W.H. De Vos, F. Houben, and R.A. Hoebe Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins Biochim Biophys Acta 1800 4 2010 448 458
14. I. Gonzalez-Suarez, A.B. Redwood, and S.M. Perkins Novel roles for A-type lamins in telomere biology and the DNA damage response pathway EMBO J 28 16 2009 2414 2427
15. F. Houben, C.H. Willems, and I.L. Declercq Disturbed nuclear orientation and cellular migration in A-type lamin deficient cells Biochim Biophys Acta 1793 2 2009 312 324
16. C.J. Hutchison, and H.J. Worman A-type lamins: guardians of the soma? Nat Cell Biol 6 11 2004 1062 1067 (Pubitemid 39468007)
17. M. Prokocimer, M. Davidovich, and M. Nissim-Rafinia Nuclear lamins: key regulators of nuclear structure and activities J Cell Mol Med 13 6 2009 1059 1085
18. H.J. Worman, L.G. Fong, A. Muchir, and S.G. Young Laminopathies and the long strange trip from basic cell biology to therapy J Clin Invest 119 7 2009 1825 1836
19. V. Andres, and J.M. Gonzalez Role of A-type lamins in signaling, transcription, and chromatin organization J Cell Biol 187 7 2009 945 957
20. R. Agrelo, F. Setien, and J. Espada Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma J Clin Oncol 23 17 2005 3940 3947 (Pubitemid 46218697)
21. J.L. Broers, Y. Raymond, and M.K. Rot Nuclear A-type lamins are differentially expressed in human lung cancer subtypes Am J Pathol 143 1 1993 211 220 (Pubitemid 24058175)
22. S.H. Kaufmann, M. Mabry, R. Jasti, and J.H. Shaper Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines Cancer Res 51 2 1991 581 586
23. S.F. Moss, V. Krivosheyev, and A. de Souza Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms Gut 45 5 1999 723 729 (Pubitemid 29492146)
24. U. Roth, H. Razawi, and J. Hommer Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma Proteomics 10 2 2010 194 202
25. B. Stadelmann, E. Khandjian, and A. Hirt Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells Leuk Res 14 9 1990 815 821
26. Available from: http://www.federa.org/?s=1&m=82&p=9&v=4#866 [accessed 10.10.11].
27. M.M. Weiss, M.A. Hermsen, and G.A. Meijer Comparative genomic hybridisation Mol Pathol 52 5 1999 243 251
28. R. Simon, M. Mirlacher, and G. Sauter Tissue microarrays Biotechniques 36 1 2004 98 105 (Pubitemid 38076386)
29. I. Zlobec, R. Steele, L. Terracciano, J.R. Jass, and A. Lugli Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer J Clin Pathol 60 10 2007 1112 1116 (Pubitemid 47612643)
30. B. Liu, J. Wang, and K.M. Chan Genomic instability in laminopathy-based premature aging Nat Med 11 7 2005 780 785 (Pubitemid 41021211)